trial
as of 2026-07-01Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"
NCTId NCT04312503
at a glance
Phase — · Completed
Enrollment 95 (actual)
Sponsored by Aziende Chimiche Riunite Angelini Francesco S.p.A
Primary completion 2022-10-31
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
95 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2020-07-13
Primary completion
2022-10-31
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
Sites
18 total
Ancona, ItalyBrescia, ItalyCagliari, ItalyCatania, ItalyCatanzaro, ItalyFoggia, ItalyGenova, ItalyLecce, ItalyMonza, ItalyMilan, ItalyMilan, ItalyMilan, Italy
Facts & assertions
4 sourced
Enrollment
95
Phase
NA
Primary Completion Date
2022-10-31
Status
COMPLETED
relationships
The graph out of here
drug
drug
drug
lead_sponsor
indication